Oncology Vol 32 No 2

home / journals / oncology / oncology-vol-32-no-2
A Tribute to Jimmie C. Holland, MD

A Tribute to Jimmie C. Holland, MD

Daniel C. McFarland, DO
February 15th 2018
Article

Long-time ONCOLOGY contributor Jimmie C. Holland, MD, a founder of the field of psycho-oncology, who worked as a powerful and effective clinician and researcher up until the very end, passed away on Christmas Eve of 2017.

POINT: Is There Still a Role for Intraperitoneal Platinum Therapy in Ovarian Cancer?

POINT: Is There Still a Role for Intraperitoneal Platinum Therapy in Ovarian Cancer?

Keiichi Fujiwara, MD, PhD
February 15th 2018
Article

Intraperitoneal (IP) chemotherapy is a reasonable treatment approach for ovarian cancer because it can directly expose the surface tissues to which the cancer has disseminated to an extremely high concentration of the chemotherapy drug.

COUNTERPOINT: Is There Still a Role for Intraperitoneal Platinum Therapy in Ovarian Cancer?

COUNTERPOINT: Is There Still a Role for Intraperitoneal Platinum Therapy in Ovarian Cancer?

Robert F. Ozols, MD, PhD
February 15th 2018
Article

There will be no further randomized phase III trials of cytotoxic IP chemotherapy; IP therapy in ovarian cancer will soon be an historical footnote along with other failed approaches in cancer care.

Site Logo

Primary Central Nervous System Lymphoma-PART 2: Modern Therapeutic Management and Future Directions

Rimas V. Lukas, MD;Vinai Gondi, MD;Roger Stupp, MD;Jeffrey J. Raizer, MD
February 15th 2018
Article

In Part 2 of this review article, we discuss the management of primary CNS lymphoma, focusing in particular on systemic therapies and radiation, as well as provide clinicians with a comprehensive overview by covering the key investigations that have brought us to our current state of knowledge, and studies that may guide future interventions.